Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 4Recruiting 3Terminated 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1

Conditions

Carcinoma, Non-Small-Cell Lung 41Breast Neoplasms 31Neoplasms 28Neoplasm Metastasis 23Melanoma 20Leukemia, Myeloid, Acute 20Prostatic Neoplasms 19Colorectal Neoplasms 17Multiple Myeloma 16Lung Neoplasms 16Recurrence 13Myelodysplastic Syndromes 13Squamous Cell Carcinoma of Head and Neck 12Lymphoma, Non-Hodgkin 12Carcinoma, Renal Cell 12Ovarian Neoplasms 11Lymphoma, Large B-Cell, Diffuse 11Carcinoma, Hepatocellular 11Urinary Bladder Neoplasms 10Uterine Cervical Neoplasms 9Pancreatic Neoplasms 9Glioblastoma 9Head and Neck Neoplasms 8Stomach Neoplasms 7Rectal Neoplasms 7Lymphoma, Follicular 7Glioma 7Brain Neoplasms 7Solid Tumor 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Hemangiosarcoma × 90 days × Clear all
NCT05826600 2026-04-24

A Study of OMX-0407 in Patients With Previously Treated Solid Tumours That Can't be Removed Surgically

iOmx Therapeutics AG

Phase 1/2 Terminated
68 enrolled
GenitourinarySarcoma

Carcinoma, Renal Cell, Hemangiosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡